Nilka R Burrows
Overview
Explore the profile of Nilka R Burrows including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhave N, Han Y, Steffick D, Bragg-Gresham J, Zivin K, Burrows N, et al.
BMJ Open
. 2024 Feb;
14(2):e073136.
PMID: 38346884
Background: Simultaneous urine testing for albumin (UAlb) and serum creatinine (SCr), that is, 'dual testing,' is an accepted quality measure in the management of diabetes. As chronic kidney disease (CKD)...
2.
Chu C, Powe N, McCulloch C, Crews D, Han Y, Bragg-Gresham J, et al.
JAMA Netw Open
. 2021 Sep;
4(9):e2127014.
PMID: 34570204
Importance: Significant racial and ethnic disparities in chronic kidney disease (CKD) progression and outcomes are well documented, as is low use of guideline-recommended CKD care. Objective: To examine guideline-recommended CKD...
3.
Chu C, McCulloch C, Banerjee T, Pavkov M, Burrows N, Gillespie B, et al.
Am J Kidney Dis
. 2020 Apr;
76(2):174-183.
PMID: 32305206
Rationale & Objective: Persons with chronic kidney disease (CKD) are often unaware of their disease status. Efforts to improve CKD awareness may be most effective if focused on persons at...
4.
Harding J, Pavkov M, Gregg E, Burrows N
Diabetes Care
. 2019 May;
42(8):1430-1435.
PMID: 31142496
Objective: Nontraumatic lower-extremity amputation (NLEA) is a complication of end-stage renal disease (ESRD) and diabetes. Although recent data show that NLEA rates in the U.S. ESRD population are declining overall,...
5.
Yarnoff B, Hoerger T, Shrestha S, Simpson S, Burrows N, Anderson A, et al.
PLoS One
. 2018 Oct;
13(10):e0205530.
PMID: 30339684
Rationale & Objective: As the prevalence of obesity continues to rise in the United States, it is important to understand its impact on the lifetime risk of chronic kidney disease...
6.
Pavkov M, Harding J, Burrows N
MMWR Morb Mortal Wkly Rep
. 2018 Mar;
67(10):289-293.
PMID: 29543788
Acute kidney injury is a sudden decrease in kidney function with or without kidney damage, occurring over a few hours or days. Diabetes, hypertension, and advanced age are primary risk...
7.
Carlos C, McCulloch C, Hsu C, Grimes B, Pavkov M, Burrows N, et al.
J Am Soc Nephrol
. 2017 Mar;
28(8):2521-2528.
PMID: 28336719
The American Society of Nephrology recommends against routine cancer screening among asymptomatic patients receiving maintenance dialysis on the basis of limited survival benefit. To determine the frequency of colorectal cancer...
8.
Yarnoff B, Hoerger T, Simpson S, Leib A, Burrows N, Shrestha S, et al.
BMC Nephrol
. 2017 Mar;
18(1):85.
PMID: 28288579
Background: Better treatment during early stages of chronic kidney disease (CKD) may slow progression to end-stage renal disease and decrease associated complications and medical costs. Achieving early treatment of CKD...
9.
Wong S, Hebert P, Laundry R, Hammond K, Liu C, Burrows N, et al.
Clin J Am Soc Nephrol
. 2016 Sep;
11(10):1825-1833.
PMID: 27660306
Background And Objectives: It is not known what proportion of United States patients with advanced CKD go on to receive RRT. In other developed countries, receipt of RRT is highly...
10.
Yarnoff B, Hoerger T, Simpson S, Pavkov M, Burrows N, Shrestha S, et al.
PLoS One
. 2016 Jul;
11(7):e0157323.
PMID: 27404556
Background: Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended...